BioSpace News Archive

Drug Development

Diabetes Leader Novo Nordisk is Making Obesity Its Top Priority

The company to host a Capital Markets Day where its R&D and commercial strategy as well as current market dynamics will be updated.

November 21, 2017
·
4 min read
Business

Tekni-Plex Announces New General Manager for China Operations

Tekni-Plex has promoted Michael Luo to general manager of its China operations. Luo joined the company in 2014 as director of sales and marketing.

November 21, 2017
·
2 min read
Business

RiboBio and GE Healthcare Enter Into a Strategic Partnership for Oligonucleotide Drug Development and Manufacturing

At the 5th CNAF in Guangzhou, China, Guangzhou RiboBio and GE Healthcare Life Sciences held a strategic partnership signing ceremony.

November 21, 2017
·
3 min read
Bio NC

Xona Microfluidics Issued European Patents for Neuron Research Device

The patents are assigned to the University of California and licensed exclusively to Xona.

November 21, 2017
·
3 min read
Business

NeuroVive Interim Report January - September 2017

Net revenues were SEK 0 and other operating income was SEK 397,000.

November 21, 2017
·
3 min read
Step Pharma Completes 14.5M Euros Series A Financing with Additional New Investor

The additional proceeds will be used to advance the company’s novel class of oral immunomodulators targeting cytidine triphosphate synthase 1 (CTPS1) to clinical studies.

November 21, 2017
·
3 min read
ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening

ICON has developed FIRECREST Pre-Screen to address the ongoing industry challenge of patient recruitment, which can represent more than 30% of total study costs.

November 21, 2017
·
3 min read
Deals

SK Capital Closes Acquisition of Perrigo’s API Business and Changes Name to Wavelength Pharmaceuticals

The API business has been renamed from Perrigo API to Wavelength Pharmaceuticals.

November 21, 2017
·
3 min read
Drug Development

Realm Therapeutics Announces Publication of Positive Preclinical Data on PR022 in the Treatment of Atopic Dermatitis

Treatment with HOCl reduced the secretion of inflammatory cytokines in affected skin tissue from NC/Nga mice, including IL-4, IL-13, and TARC.

November 21, 2017
·
4 min read
Policy

U.S. FDA Accepts Regulatory Submission and Grants Priority Review for U.S. WorldMeds’ Lofexidine

During lofexidine’s development, the FDA granted it Fast Track Status, a process designed to facilitate and expedite the review of drugs to treat serious conditions and fill an unmet medical need.

November 21, 2017
·
3 min read